Neovasc develops, manufactures and markets innovative vascular devices. Our products include the Neovasc Reducer™ for refractory angina and PeriPatch™ surgical tissue.

We also offer pericardial tissue processing, vascular product development and design and manufacturing solutions to industry partners.

Neovasc is headquartered in Vancouver, Canada. Our products are approved for sale and distribution worldwide.

 

 

Latest News

May 14, 2012
Neovasc's Tiara Transcatheter Mitral Valve Program Preclinical Data to be Presented at EuroPCR 2012 (33KB PDF)

March 8, 2012
Neovasc Named Medical Device Company of the Year by LifeSciences BC (28KB PDF)

 


Neovasc Investor Presentation